Literature DB >> 23027770

Growth hormone variants: a potential avenue for a better diagnostic characterization of growth hormone deficiency in children.

A E Rigamonti1, M Bozzola, G Banfi, C Meazza, E E Müller, S G Cella.   

Abstract

Human GH (hGH) is a heterogeneous protein hormone consisting of several isoforms. This heterogeneity is the consequence of multiple hGH genes, mRNA splicing, post-translational modifications, and peripheral metabolism, and it represents one important reason for the disparity among GH assay results from different laboratories. However, other factors are involved: a) interference from endogenous GH binding proteins; b) different specificities of anti- GH (monoclonal and polyclonal) antibodies; c) different matrix effects among the calibrators; d) the use of different calibrators. The measurement of GH levels in response to provocative testing is an essential part of the diagnosis of GH deficiency. For this purpose, an accurate, reproducible and universally valid GH measurement would be highly desirable, but, despite a huge number of efforts in clinical biochemistry, this goal remains elusive.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23027770     DOI: 10.3275/8647

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   5.467


  69 in total

Review 1.  The need to revise the cut-off level for the diagnosis of GH deficiency in children.

Authors:  Yardena Tenenbaum-Rakover
Journal:  Pediatr Endocrinol Rev       Date:  2008-06

2.  Identification of transformed alpha 2-macroglobulin as a growth hormone-binding protein in human blood.

Authors:  J Kratzsch; T Selisko; G Birkenmeier
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

3.  Molecular cloning of cDNA encoding 20 kDa variant human growth hormone and the alternative splicing mechanism.

Authors:  N Masuda; M Watahiki; M Tanaka; M Yamakawa; K Shimizu; J Nagai; K Nakashima
Journal:  Biochim Biophys Acta       Date:  1988-01-25

4.  European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency.

Authors:  Anders Juul; Sergio Bernasconi; Peter E Clayton; Wieland Kiess; Sabine DeMuinck-Keizer Schrama
Journal:  Horm Res       Date:  2002

5.  Response to long-term growth hormone therapy in short children with reduced GH bioactivity.

Authors:  Paola Travaglino; Fabio Buzi; Cristina Meazza; Sara Pagani; Carmine Tinelli; Lorenzo Iughetti; Vincenzo De Sanctis; Gianluca Aimaretti; Dimitri Poddighe; Salvatore Barberi; Mauro Bozzola
Journal:  Horm Res       Date:  2006-07-11

Review 6.  Structure and properties of members of the hGH family: a review.

Authors:  U J Lewis; Y N Sinha; G P Lewis
Journal:  Endocr J       Date:  2000-03       Impact factor: 2.349

7.  Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement.

Authors:  C J Strasburger; Z Wu; C D Pflaum; R A Dressendörfer
Journal:  J Clin Endocrinol Metab       Date:  1996-07       Impact factor: 5.958

8.  Biological characterization of charge isomers of human growth hormone.

Authors:  A Skottner; A Forsman; B Skoog; J L Kostyo; C M Cameron; N A Adamafio; K G Thorngren; M Hagerman
Journal:  Acta Endocrinol (Copenh)       Date:  1988-05

9.  Interpretation of growth hormone provocative tests: comparison of cut-off values in four European laboratories.

Authors:  A M Andersson; H Orskov; M B Ranke; S Shalet; N E Skakkebaek
Journal:  Eur J Endocrinol       Date:  1995-03       Impact factor: 6.664

10.  Isotopic and nonisotopic assays for measuring somatotropin compared: re-evaluation of cutoff value in provocative tests.

Authors:  G Banfi; M Marinelli; E Casari; M Murone; P Bonini
Journal:  Clin Chem       Date:  1991-02       Impact factor: 8.327

View more
  1 in total

1.  Revaluation of the clinical and metabolic behavior of children with isolated growth hormone deficiency during GH treatment according to newly proposed note 39 of the Italian Medicines Agency (AIFA).

Authors:  A Ciresi; F Cicciò; M C Amato; C Giordano
Journal:  J Endocrinol Invest       Date:  2015-05-27       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.